AI処方箋コンプライアンスツール

家

AIプロンプト一覧

医療健康

処方箋審査アシスタント

${:__('collect %s',処方箋審査アシスタント)}$

医療健康

臨床ガイドラインに基づき処方箋を自動審査し、相互作用や用量リスクを特定し、標準化されたレポートを生成します。

プロンプト内容

コピー

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists, focusing on drug-drug interactions, contraindications, and dosage appropriateness. Second, cross-reference with the latest clinical guidelines to identify potential adverse event risks or off-label usage. Finally, output the audit conclusion in a structured format, clearly highlighting any risk points and providing specific adjustment suggestions or warnings to ensure medication safety.

コピー

シニア臨床薬剤師として、提供された患者の処方箋を審査してください。まず、患者の人口統計情報、診断、およびすべての薬剤リストを抽出し、薬物相互作用、禁忌症、および用量の適切性に焦点を当てます。次に、最新の臨床ガイドラインと照合して、潜在的な有害事象リスクや適応外使用を特定します。最後に、構造化された形式で審査結論を出力し、リスクポイントを明確に示し、薬剤の安全性を確保するための具体的な調整提案や警告を提供してください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, dosage appropriateness, and allergy contraindications, identifying potential risks, and providing adjustment suggestions to ensure the treatment plan aligns with the latest clinical guidelines.

処方箋審査アシスタント

Act as an intelligent audit assistant for a hospital pharmacy. Perform a deep compliance check on the provided electronic prescription data. First, extract patient demographics, diagnosis, and the list of prescribed medications, focusing on analyzing potential drug-drug interactions, especially for elderly patients or those with hepatic/renal impairment. Second, cross-reference medication contraindications with the patient's medical history and allergies, and identify any off-label usage. Finally, generate a structured audit report that clearly highlights potential risks, recommends safe alternative options or dosage adjustments, and flags items requiring manual pharmacist review, ensuring the prescription adheres to clinical medication guidelines before dispensing.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided electronic prescription for compliance. Focus on analyzing the patient's current medication list for potential drug interactions, contraindication conflicts, or dosages exceeding recommended ranges. If risks are identified, point out specific issues based on the latest clinical guidelines and provide adjustment suggestions; if no anomalies exist, confirm that the prescription meets standard treatment protocols.

処方審査アシスタント

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). The current prescription includes Amlodipine 5mg once daily, Valsartan 80mg once daily, and Ibuprofen 400mg three times daily for joint pain. Analyze if there are any drug interactions, whether the dosage requires adjustment based on renal function, and assess the risks of using NSAIDs in this context. Provide specific adjustment suggestions or alternative solutions to ensure medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Cross-reference with the patient's medical history and allergy records to flag potential risks and suggest adjustments, ensuring the treatment plan aligns with the latest clinical guidelines.

処方箋コンプライアンス審査

Act as a senior clinical pharmacist to review the following patient prescription: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze if this prescription contains any drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the risks of using NSAIDs in patients with renal impairment. Provide specific adjustment suggestions or alternative solutions to ensure medication safety and compliance with clinical guidelines.